Implementation of a registry and open access genetic testing program for inherited retinal diseases within a non‐profit foundation
dc.contributor.author | Mansfield, Brian C. | |
dc.contributor.author | Yerxa, Benjamin R. | |
dc.contributor.author | Branham, Kari H. | |
dc.date.accessioned | 2020-10-01T23:30:56Z | |
dc.date.available | WITHHELD_12_MONTHS | |
dc.date.available | 2020-10-01T23:30:56Z | |
dc.date.issued | 2020-09 | |
dc.identifier.citation | Mansfield, Brian C.; Yerxa, Benjamin R.; Branham, Kari H. (2020). "Implementation of a registry and open access genetic testing program for inherited retinal diseases within a non‐profit foundation." American Journal of Medical Genetics Part C: Seminars in Medical Genetics 184(3): 838-845. | |
dc.identifier.issn | 1552-4868 | |
dc.identifier.issn | 1552-4876 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/162760 | |
dc.description.abstract | The Foundation Fighting Blindness is a 50‐year old 501c(3) non‐profit organization dedicated to supporting the development of treatments and cures for people affected by the inherited retinal diseases (IRD), a group of clinical diagnoses that include orphan diseases such as retinitis pigmentosa, Usher syndrome, and Stargardt disease, among others. Over $760 M has been raised and invested in preclinical and clinical research and resources. Key resources include a multi‐national clinical consortium, an international patient registry with over 15,700 members that is expanding rapidly, and an open access genetic testing program that provides no cost comprehensive genetic testing to people clinically diagnosed with an IRD living in the United States. These programs are described with particular focus on the challenges and outcomes of establishing the registry and genetic testing program. | |
dc.publisher | John Wiley & Sons, Inc. | |
dc.subject.other | clinical consortium | |
dc.subject.other | venture philanthropy | |
dc.subject.other | patient registry | |
dc.subject.other | open access genetic testing | |
dc.subject.other | inherited retinal diseases | |
dc.title | Implementation of a registry and open access genetic testing program for inherited retinal diseases within a non‐profit foundation | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Human Genetics | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/162760/2/ajmgc31825_am.pdf | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/162760/1/ajmgc31825.pdf | en_US |
dc.identifier.doi | 10.1002/ajmg.c.31825 | |
dc.identifier.source | American Journal of Medical Genetics Part C: Seminars in Medical Genetics | |
dc.identifier.citedreference | Sangermano, R., Garanto, A., Khan, M., Runhart, E. H., Bauwens, M., Bax, N. M., … Cremers, F. P. M. ( 2019 ). Deep‐intronic ABCA4 variants explain missing heritability in Stargardt disease and allow correction of splice defects by antisense oligonucleotides. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 21 ( 8 ), 1751 – 1760. https://doi.org/10.1038/s41436-018-0414-9 | |
dc.identifier.citedreference | Cella, D., Choi, S. W., Condon, D. M., Schalet, B., Hays, R. D., Rothrock, N. E., … Reeve, B. B. ( 2019 ). PROMIS([R]) adult health profiles: Efficient short‐form measures of seven health domains. Value in Health, 22 ( 5 ), 537 – 544. https://doi.org/10.1016/j.jval.2019.02.004 | |
dc.identifier.citedreference | Cremers, F. P. M., Boon, C. J. F., Bujakowska, K., & Zeitz, C. ( 2018 ). Special issue introduction: Inherited retinal disease: Novel candidate genes, genotype‐phenotype correlations, and inheritance models. Genes (Basel), 9 ( 4 ), 215. https://doi.org/10.3390/genes9040215 | |
dc.identifier.citedreference | Daiger, S. P., Bowne, S. J., & Sullivan, L. S. ( 2007 ). Perspective on genes and mutations causing retinitis pigmentosa. Archives of Ophthalmology, 125 ( 2 ), 151 – 158. https://doi.org/10.1001/archopht.125.2.151 | |
dc.identifier.citedreference | Daiger, S. P., Rossiter, B. J. F., Greenberg, J., Christoffels, A., & Hide, W. ( 1998 ). Data services and software for identifying genes and mutations causing retinal degeneration. Investigative Ophthalmology & Visual Science, 39, s295. | |
dc.identifier.citedreference | Daiger, S. P., Sullivan, L. S., & Bowne, S. J. ( 2013 ). Genes and mutations causing retinitis pigmentosa. Clinical Genetics, 84 ( 2 ), 132 – 141. https://doi.org/10.1111/cge.12203 | |
dc.identifier.citedreference | Dryja, T. P., McGee, T. L., Reichel, E., Hahn, L. B., Cowley, G. S., Yandell, D. W., … Berson, E. L. ( 1990 ). A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature, 343 ( 6256 ), 364 – 366. https://doi.org/10.1038/343364a0 | |
dc.identifier.citedreference | Duncan, J. L., Liang, W., Maguire, M. G., Audo, I., Ayala, A. R., Birch, D. G., … Sahel, J.‐A. ( 2020 ). Baseline visual field findings in the RUSH2A study: Associated factors and correlation with other measures of disease severity. American Journal of Ophthalmology. https://doi.org/10.1016/j.ajo.2020.05.024 | |
dc.identifier.citedreference | Farrar, G. J., Kenna, P., Redmond, R., McWilliam, P., Bradley, D. G., Humphries, M. M., … Humphries, P. ( 1990 ). Autosomal dominant retinitis pigmentosa: Absence of the rhodopsin proline→histidine substitution (codon 23) in pedigrees from Europe. American Journal of Human Genetics, 47 ( 6 ), 941 – 945. | |
dc.identifier.citedreference | Fisher, J. K., Bromley, R. L., & Mansfield, B. C. ( 2016 ). My retina tracker™: An on‐line international registry for people affected with inherited orphan retinal degenerative diseases and their genetic relatives—A new resource. In C. Bowes Rickman, M. M. LaVail, R. E. Anderson, C. Grimm, J. Hollyfield, & J. Ash (Eds.), Retinal degenerative diseases (Vol. 854, pp. 245 – 251 ). Cham: Springer International Publishing. | |
dc.identifier.citedreference | Haer‐Wigman, L., van Zelst‐Stams, W. A., Pfundt, R., van den Born, L. I., Klaver, C. C., Verheij, J. B., … Yntema, H. G. ( 2017 ). Diagnostic exome sequencing in 266 Dutch patients with visual impairment. European Journal of Human Genetics: EJHG, 25 ( 5 ), 591 – 599. https://doi.org/10.1038/ejhg.2017.9 | |
dc.identifier.citedreference | Hanany, M., Rivolta, C., & Sharon, D. ( 2020 ). Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases. Proceedings of the National Academy of Sciences of the United States of America, 117 ( 5 ), 2710 – 2716. https://doi.org/10.1073/pnas.1913179117 | |
dc.identifier.citedreference | Leroy, B. P., Pennesi, M. E., & Ohnsman, C. M. ( 2018, July). Brave new world: Gene therapy for retinal disease. Eyenet Supplement. | |
dc.identifier.citedreference | Pontikos, N., Arno, G., Jurkute, N., Schiff, E., Ba‐Abbad, R., Malka, S., … Mahroo, O. A. ( 2020 ). Genetic basis of inherited retinal disease in a molecularly characterized cohort of more than 3000 families from the United Kingdom. Ophthalmology. https://doi.org/10.1016/j.ophtha.2020.04.008 | |
dc.identifier.citedreference | Sahel, J.‐A., Marazova, K., & Audo, I. ( 2015 ). Clinical characteristics and current therapies for inherited retinal degenerations. Cold Spring Harbor Perspectives in Medicine, 5 ( 2 ), a017111. https://doi.org/10.1101/cshperspect.a017111 | |
dc.identifier.citedreference | Shaberman, B., & Durham, T. ( 2019 ). The Foundation Fighting Blindness plays an essential and expansive role in driving genetic research for inherited retinal diseases. Genes, 10 ( 7 ), 511. | |
dc.identifier.citedreference | Sharon, D., Ben‐Yosef, T., Goldenberg‐Cohen, N., Pras, E., Gradstein, L., Soudry, S., … Perlman, I. ( 2020 ). A nationwide genetic analysis of inherited retinal diseases in Israel as assessed by the Israeli inherited retinal disease consortium (IIRDC). Human Mutation, 41 ( 1 ), 140 – 149. https://doi.org/10.1002/humu.23903 | |
dc.identifier.citedreference | Stone, E. M., Andorf, J. L., Whitmore, S. S., DeLuca, A. P., Giacalone, J. C., Streb, L. M., … Tucker, B. A. ( 2017 ). Clinically focused molecular investigation of 1000 consecutive families with inherited retinal disease. Ophthalmology, 124, 1314 – 1331. https://doi.org/10.1016/j.ophtha.2017.04.008 | |
dc.identifier.citedreference | Strauss, R. W., Kong, X., Bittencourt, M. G., Ho, A., Jha, A., Schonbach, E. M., … SMART Study Group. ( 2019 ). Scotopic Microperimetric assessment of rod function in Stargardt disease (SMART) study: Design and baseline characteristics (Report no. 1). Ophthalmic Research, 61, 36 – 43. https://doi.org/10.1159/000488711 | |
dc.identifier.citedreference | Vervoort, R., Lennon, A., Bird, A. C., Tulloch, B., Axton, R., Miano, M. G., … Wright, A. F. ( 2000 ). Mutational hot spot within a new RPGR exon in X‐linked retinitis pigmentosa. Nature Genetics, 25 ( 4 ), 462 – 466. https://doi.org/10.1038/78182 | |
dc.identifier.citedreference | Vervoort, R., & Wright, A. F. ( 2002 ). Mutations of RPGR in X‐linked retinitis pigmentosa (RP3). Human Mutation, 19 ( 5 ), 486 – 500. https://doi.org/10.1002/humu.10057 | |
dc.identifier.citedreference | Zampaglione, E., Kinde, B., Place, E. M., Navarro‐Gomez, D., Maher, M., Jamshidi, F., … Bujakowska, K. M. ( 2020 ). Copy‐number variation contributes 9% of pathogenicity in the inherited retinal degenerations. Genetics in Medicine: Official Journal of the American College of Medical Genetics., 22, 1079 – 1087. https://doi.org/10.1038/s41436-020-0759-8 | |
dc.identifier.citedreference | Achroma_Corp. ( 2018 ). Achroma Corp. announces global survey results of 226 people with achromatopsia. Achroma Corp. Retrieved from https://www.achromacorp.org/PatientJourney.html. | |
dc.identifier.citedreference | Beltran, W. A. ( 2009 ). The use of canine models of inherited retinal degeneration to test novel therapeutic approaches. Veterinary Ophthalmology, 12 ( 3 ), 192 – 204. https://doi.org/10.1111/j.1463-5224.2009.00694.x | |
dc.identifier.citedreference | Bronstein, R., Capowski, E. E., Mehrotra, S., Jansen, A. D., Navarro‐Gomez, D., Maher, M., … Pierce, E. A. ( 2020 ). A combined RNA‐seq and whole genome sequencing approach for identification of non‐coding pathogenic variants in single families. Human Molecular Genetics, 29 ( 6 ), 967 – 979. https://doi.org/10.1093/hmg/ddaa016 | |
dc.identifier.citedreference | Bujakowska, K. M., Fernandez‐Godino, R., Place, E., Consugar, M., Navarro‐Gomez, D., White, J., … Pierce, E. A. ( 2016 ). Copy‐number variation is an important contributor to the genetic causality of inherited retinal degenerations. Genetics in Medicine, 19, 643 – 651. https://doi.org/10.1038/gim.2016.158 | |
dc.identifier.citedreference | Craig, B. M., Reeve, B. B., Brown, P. M., Cella, D., Hays, R. D., Lipscomb, J., Simon Pickard, A., Revicki, D. A. ( 2014 ). US Valuation of Health Outcomes Measured Using the PROMIS‐29. Value in Health, 17 ( 8 ), 846 – 853. http://dx.doi.org/10.1016/j.jval.2014.09.005. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.